Cargando…

P1102: IBRUTINIB AND RITUXIMAB AS FIRST LINE THERAPY FOR MANTLE CELL LYMPHOMA: UPDATED OUTCOMES FROM A MULTICENTRE, REAL-WORLD UK STUDY

Detalles Bibliográficos
Autores principales:	Shotton, Rohan, Tivey, Ann, Eyre, Toby A., Lewis, David, Allchin, Rebecca, Walter, Harriet, Miall, Fiona, Zhao, Rui, Santarsieri, Anna, Mcculloch, Rory, Bishton, Mark, Willimott, Victoria, Fowler, Nicole, Bedford, Claudia, Goddard, Jack, Protheroe, Samuel, Prahladan, Mahesh, Reeve, Miriam, Paneesha, Shankara, Marr, Helen, Wilson, Jamie, Ediriwickrema, Kushani, Knott, Chloe, Wrench, David, Talbot, Georgina, Linton, Kim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430971/ http://dx.doi.org/10.1097/01.HS9.0000971304.81687.8d

Ejemplares similares